Richard Moore

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Kidney function and the risk of cardiovascular events in HIV-1-infected patients

Elizabeth C. George, Gregory M. Lucas, Girish N. Nadkarni et al. · AIDS · 2010 · 82 citations

Medicine, Infectious Diseases, Nephrology +14

Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial

Joseph Doyle, Daniela K van Santen, David Iser et al. · Clinical Infectious Diseases · 2020 · 42 citations

Life Sciences, Infectious Disease Control, Infectious Diseases +17

Use of urine specific gravity to improve screening for albuminuria

Richard Moore, Cheryl A. I. Hirata‐Dulas, B L Kasiske · Kidney International · 1997 · 40 citations · Full text

Medicine, Nephrology, Renal Pathophysiology +8

Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort

Rushina Cholera, Brian W. Pence, Angela M. Bengtson et al. · PLoS ONE · 2017 · 32 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17